Kazda, Christof M <br/><br/>
Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.  [electronic resource] 

 -  Diabetes care  06 2017 
 - 808 p.  digital 
<br/><br/> Publication Type: Journal Article; Published Erratum 
<br/><br/><label>ISSN: </label>1935-5548 
<br/><br/><label>Standard No.: </label>10.2337/dc17-er06  doi